Sumary of 3 Biotechs That Could Make Big Acquisitions This Year:
- In this Motley Fool Live video recorded on July 14, Motley Fool contributors Keith Speights and Brian Orelli discuss which biotechs are most likely to make big acquisitions this year.
- Keith Speights: Hey, and speaking of acquisitions, Jefferies analyst Michael Yee thinks that big drugmakers could be forking over plenty of cash in the second half of this year to make deals.
- Do you agree with the analyst that more acquisitions will be on the way?
- Speights: Of the three, I think Vertex might historically, anyway, be a little pickier about making deals.